Seeking Alpha

BrainStorm stem cells helps patient with Lou Gehrig's disease

  • BrainStorm Cell Therapeutics' (BCLI) NurOwn adult stem cells helped a patient with Lou Gehrig's Disease and myasthenia gravis (MG) show significant improvement in cognition, speech, and muscle power a month after treatment.
  • After six months, the patient's symptoms had worsened again but improved when he was given another injection of NurOwn.
  • "The results suggest that repeated therapy may maintain and enhance the clinical benefits of NurOwn cell therapy in neurological diseases," a case report that is being published in "Muscle & Nerve" says.
  • BrainStorm expects to finalize a Phase IIa clinical trial in H1.
  • Shares are +5.6%. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: